Turkish SME supported with SME Phase I award is looking for a Biotech company and a University research group for joint Eurostars grant application
A biopharmaceutical SME from Turkey is developing a Eurostars proposal to profile MEIS oncogene in patient derived tumor organoids and xenografts models and outline the potential of the first-in-class MEIS inhibitors. Partners sought: A company and a university research group with expertise in ex vivo cancer PDX models, organoids, in vivo efficacy in animal models and diagnostic development are sought.